Concomitant and Feasible Treatment With Dasatinib and the Anti-Egfr Antibody Cetuximab Plus Radiotherapy in a CML Patient With Multiple Squamous Neoplasias

Acta Oncologica - United Kingdom
doi 10.3109/02841860903302913
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Place in Concomitant Use With Anti-Egfr Radiotherapy in Locally Advanced Head and Neck Cancer Treatment

Meandros Medical and Dental Journal
2018English

Dasatinib Worsens the Effect of Cetuximab in Combination With Fractionated Radiotherapy in FaDu- And A431-Derived Xenografted Tumours

British Journal of Cancer
Cancer ResearchOncology
2014English

Aberrant HER3 Ligand Heregulin-Expressing Head and Neck Squamous Cell Carcinoma Is Resistant to Anti-Egfr Antibody Cetuximab, but Not Second-Generation EGFR-TKI

Oncogenesis
Cancer ResearchMolecular Biology
2019English

GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View Beyond Cetuximab

Chemotherapy Research and Practice
2012English

Cetuximab PET Delineated Changes in Cellular Distribution of EGFR Upon Dasatinib Treatment in Triple Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2020English

A Novel Anti-Egfr mAb Ame55 With Lower Toxicity and Better Efficacy Than Cetuximab When Combined With Irinotecan

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Phase 1 Study of EGFR-antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives

Cancer
Cancer ResearchOncology
2018English

Combination Treatment With Hypofractionated Radiotherapy Plus IL-2/anti-IL-2 Complexes and Its Theranostic Evaluation

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy